Review
Copyright ©The Author(s) 2025.
World J Transplant. Jun 18, 2025; 15(2): 101005
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.101005
Table 6 Studies describing amiodarone use in atrial arrhythmias following lung transplantation, n (%)
Ref.
Year
Study type
Atrial fibrillation patients
Amiodarone use
Notes
Magnusson et al[53]2022Case series
15963 (40)Amiodarone increase mortality but not chronic lung allograft dysfunction
Hathaway et al[43]2021Case series
10277 (79)No difference between amiodarone and others. Safe to use
Kim et al[44]2020Case series 466 (13)No mention of any amiodarone related adverse effect
Barnes et al[45]2020Case control study10048 (alone), 26 (combination)Recommend amiodarone as the first drug to be used
Malik et al[34]2013Case series2724 (88.9)No mention of any amiodarone related adverse effect
Isiadinso et al[35]2011Case series6238 (65)24 out of 38 (64%) of patients treated with amiodarone died
Diaz-Guzman et al[81]2009Case report11 patientAmiodarone pulmonary toxicity–resolved with cessation and steroids